MFN Partners, LP 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 3:36 pm Sale |
2024-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
MFN Partners, LP | 0 0.000% |
-121,384 (Position Closed) |
Filing |
| 2021-02-12 5:09 pm Purchase |
2020-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
MFN Partners, LP | 121,384 7.150% |
46,990 (+63.16%) |
Filing |